Search Results - "Braudeau, J"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice by Braudeau, J, Delatour, B, Duchon, A, Pereira, P Lopes, Dauphinot, L, de Chaumont, F, Olivo-Marin, J-C, Dodd, RH, Hérault, Y, Potier, M-C

    Published in Journal of psychopharmacology (Oxford) (01-08-2011)
    “…An imbalance between inhibitory and excitatory neurotransmission has been proposed to contribute to altered brain function in individuals with Down syndrome…”
    Get full text
    Journal Article
  2. 2

    Specific targeting of the GABA-A receptor alpha 5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice by Braudeau, J, Delatour, B, Duchon, A, Pereira, P Lopes, Dauphinot, L, de Chaumont, F, Olivo-Marin, J-C, Dodd, R H, Herault, Y, Potier, M-C

    Published in Journal of psychopharmacology (Oxford) (01-08-2011)
    “…An imbalance between inhibitory and excitatory neurotransmission has been proposed to contribute to altered brain function in individuals with Down syndrome…”
    Get full text
    Journal Article
  3. 3

    Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer’s Disease Predementia by Souchet, B., Audrain, M., Alves, S., Fol, R., Tada, S., Orefice, N. S., Potier, B., Dutar, P., Billard, J.-M., Cartier, Nathalie, Braudeau, Jérôme

    “…Background Though our understanding of Alzheimer’s disease (AD) remains elusive, it is well known that the disease starts long before the first signs of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats by Souchet, B., Audrain, M., Gu, Y., Lindberg, M. F., Orefice, N. S., Rey, E., Cartier, N., Janel, N., Meijer, L., Braudeau, Jérôme

    “…Background Alzheimer’s disease (AD) is a continuum of events beginning with an increase in brain soluble Aβ342 followed by the appearance of…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Reducing GABAergic inhibition restores cognitive functions in a mouse model of Down syndrome by Potier, Marie-Claude, Braudeau, Jérôme, Dauphinot, Luce, Delatour, Benoît

    Published in CNS & neurological disorders drug targets (01-02-2014)
    “…Alterations in excitatory-inhibitory balance occur in Down syndrome and could be responsible for cognitive deficits observed through the life of all…”
    Get more information
    Journal Article
  10. 10

    Activation Of Proinflammatory Caspases by Cathepsin B in Focal Cerebral Ischemia by Benchoua, Alexandra, Braudeau, Jérôme, Reis, Aurélia, Couriaud, Cécile, Onténiente, Brigitte

    “…Cathepsins and caspases are two families of proteases that play pivotal roles in ischemic cell death. This study investigated the existence of a cross-talk…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Specific targeting of the GABA-A receptor [alpha]5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice by Braudeau, J, Delatour, B, Duchon, A, Pereira, P Lopes, Dauphinot, L, de Chaumont, F, Olivo-Marin, J-C, Dodd, RH, Hérault, Y, Potier, M-C

    Published in Journal of psychopharmacology (Oxford) (01-08-2011)
    “…An imbalance between inhibitory and excitatory neurotransmission has been proposed to contribute to altered brain function in individuals with Down syndrome…”
    Get full text
    Journal Article
  13. 13

    PTD–XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms by Guégan, Christelle, Braudeau, Jérôme, Couriaud, Cécile, Dietz, Gunnar P.H., Lacombe, Pierre, Bähr, Mathias, Nosten-Bertrand, Marika, Onténiente, Brigitte

    Published in Neurobiology of disease (01-04-2006)
    “…Caspases play a major role in the infarction process that follows occlusion of cerebral arteries and are important targets for stroke therapy. We have…”
    Get full text
    Journal Article
  14. 14

    The mechanisms of cell death in focal cerebral ischemia highlight neuroprotective perspectives by anti-caspase therapy by Onténiente, Brigitte, Couriaud, Cécile, Braudeau, Jérôme, Benchoua, Alexandra, Guégan, Christelle

    Published in Biochemical pharmacology (15-10-2003)
    “…A number of studies have validated the importance of caspase activation in ischemia-induced brain damage. Caspases participate in both the initiation and…”
    Get full text
    Journal Article Conference Proceeding
  15. 15